A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function

Clinical trial NCT02161224 · COMPLETED

Trial details

NCT number: NCT02161224
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

PK of FG-4592 Hepatic Insufficiency Healthy Subjects

Start date: 2013-09-01
Primary completion: 2013-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.